DNA methylation signature (SAM40) identifies subgroups of the Luminal A breast cancer samples with distinct survival.
- DOI
- 10.18632/oncotarget.13718
- Published
- 2017 Jan 3
- Container
- Oncotarget
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.18632/oncotarget.13718,
title = {DNA methylation signature (SAM40) identifies subgroups of the Luminal A breast cancer samples with distinct survival.},
author = {Fleischer T and Klajic J and Aure MR and Louhimo R and Pladsen AV and Ottestad L and Touleimat N and Laakso M and Halvorsen AR and Grenaker Alnæs GI and Riis ML and Helland Å and Hautaniemi S and Lønning PE and Naume B and Børresen-Dale AL and Tost J and Kristensen VN},
year = {2017},
journal = {Oncotarget},
doi = {10.18632/oncotarget.13718},
url = {https://doi.org/10.18632/oncotarget.13718}
}RIS
TY - JOUR TI - DNA methylation signature (SAM40) identifies subgroups of the Luminal A breast cancer samples with distinct survival. AU - Fleischer T AU - Klajic J AU - Aure MR AU - Louhimo R AU - Pladsen AV AU - Ottestad L AU - Touleimat N AU - Laakso M AU - Halvorsen AR AU - Grenaker Alnæs GI AU - Riis ML AU - Helland Å AU - Hautaniemi S AU - Lønning PE AU - Naume B AU - Børresen-Dale AL AU - Tost J AU - Kristensen VN PY - 2017 JO - Oncotarget DO - 10.18632/oncotarget.13718 UR - https://doi.org/10.18632/oncotarget.13718 ER -
APA
T, F., J, K., MR, A., R, L., AV, P., L, O., N, T., M, L., AR, H., GI, G. A., ML, R., Å, H., S, H., PE, L., B, N., AL, B., J, T., & VN, K. (2017). DNA methylation signature (SAM40) identifies subgroups of the Luminal A breast cancer samples with distinct survival.. Oncotarget. https://doi.org/10.18632/oncotarget.13718
Source records
- pubmed · retrieved 2026-09-26T17:41:02.746Z